Online citations, reference lists, and bibliographies.
← Back to Search

Causes Of Death In People With Liver Cirrhosis In England Compared With The General Population: A Population-Based Cohort Study

S. Ratib, K. Fleming, C. Crooks, A. Walker, J. West
Published 2015 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
OBJECTIVES:There is a need for unbiased estimates of cause-specific mortality by etiology in patients with liver cirrhosis. The aim of this study is to use nationwide linked electronic routine healthcare data from primary and secondary care alongside the national death registry data to report such estimates.METHODS:We identified from the linked Clinical Practice Research Datalink (CPRD) and English Hospital Episode Statistics adults with an incident diagnosis of liver cirrhosis linked to the Office for National Statistics between 1998 and 2009. Age-matched controls from the CPRD general population were selected. We calculated the cumulative incidence (adjusting for competing risks) and excess risk of death by 5 years from diagnosis for different causes of death, stratified by etiology and stage of disease.RESULTS:Five thousand one hundred and eighteen patients with cirrhosis were matched to 152,903 controls. Among compensated patients, the 5-year excess risk of liver-related death was higher than that of any other cause of death for all patients, except those of unspecified etiology. For example, those of alcohol etiology had 30.8% excess risk of liver-related death (95% confidence interval (CI): 27.9%, 33.1%) compared with 9.9% excess risk of non-liver-related death. However, patients of unspecified etiology had a higher excess risk of non-liver-related compared with liver-related death (10.7% vs. 6.7%). This was due to a high excess risk of non-liver neoplasm death (7.7%, 95% CI: 5.9%, 9.5%). All decompensated patients had a higher excess of liver-related mortality than any other cause.CONCLUSIONS:In order to reduce associated mortality among people with liver cirrhosis, patients’ care pathways need to be tailored depending on the etiology and stage of the disease.
This paper references
Th e analysis of failure times in the presences of competing risks
RL Prentice (2012)
10.1002/sim.3762
Estimating the crude probability of death due to cancer and other causes using relative survival models.
P. Lambert (2010)
Th e spectrum expanded : cryptogenic cirrhosis and the natural history of non - alcoholic fatty liver disease
SH Caldwell (2004)
10.1136/bmj.282.6260.263
A 20-year prospective study of cirrhosis.
J. B. Saunders (1981)
Th e communication of a secondary care diagnosis of autoimmune hepatitis to primary care practitioners : a population - based study
F Varyani (1995)
10.1111/j.1572-0241.2002.07057.x
Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients
G. Fattovich (2002)
10.1371/journal.pmed.1001437
Excess Long-Term Mortality following Non-Variceal Upper Gastrointestinal Bleeding: A Population-Based Cohort Study
C. Crooks (2013)
Inaccuracies of death certificate information.
W. Flanders (1992)
Th e UK General Practice Research Database
T Walley
10.1111/j.1365-2125.2009.03537.x
Validation and validity of diagnoses in the General Practice Research Database: a systematic review
E. Herrett (2010)
10.1016/j.jhep.2012.12.005
The burden of liver disease in Europe: a review of available epidemiological data.
M. Blachier (2013)
Medicines and Healthcare Products Regulatory Agency . Data Quality Assessment in CPRD Crown Copyright : London
(2007)
Death certifi cation and the epidemiologist
T Devis (2005)
10.1634/theoncologist.2009-0285
Obesity and Cancer
K. Wolin (2010)
10.1093/PUBMED/FDG058
Trends in mortality rates comparing underlying-cause and multiple-cause coding in an English population 1979-1998.
M. Goldacre (2003)
10.1016/j.jhep.2005.05.009
Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension.
R. de Franchis (2005)
10.1016/S0895-4356(02)00531-0
Long-term survival and cause-specific mortality in patients with cirrhosis of the liver: a nationwide cohort study in Denmark.
H. Sørensen (2003)
10.1016/J.JHEP.2010.06.004
Revising consensus in portal hypertension: Report of the Baveno V Consensus Workshop on methodology of diagnosis and therapy in Portal Hypertension
R. Franchis (2005)
10.1016/S0140-6736(97)04248-7
The UK General Practice Research Database
T. Walley (1997)
10.1002/1097-0258(20000715)19:13<1729::AID-SIM484>3.0.CO;2-9
Cumulative cause-specific mortality for cancer patients in the presence of other causes: a crude analogue of relative survival.
K. Cronin (2000)
10.1016/j.canep.2012.08.012
The impact of under and over-recording of cancer on death certificates in a competing risks analysis: a simulation study.
S. R. Hinchliffe (2013)
Assessment of the completeness and accuracy of computer medical records in four practices committed to recording data on computer.
M. Pringle (1995)
10.1053/j.gastro.2013.09.019
Development and validation of a comorbidity scoring system for patients with cirrhosis.
P. Jepsen (2014)
10.1016/J.JHEP.2004.02.013
The spectrum expanded: cryptogenic cirrhosis and the natural history of non-alcoholic fatty liver disease.
S. Caldwell (2004)
Rules and guidelines for mortality and morbidity coding. Mortality . In: DIMDI ed International Classifi cation of Disease and Related Health Problems
(2004)
10.7326/0003-4819-157-9-201211060-00022
Risk for Hepatocellular Carcinoma in Patients With Alcoholic Cirrhosis
H. Tillman (2012)
10.1016/j.cgh.2012.08.011
Incidence of hepatocellular carcinoma among US patients with cirrhosis of viral or nonviral etiologies.
R. D. Mair (2012)
10.1186/1471-2458-12-329
The impact of the Quality and Outcomes Framework (QOF) on the recording of smoking targets in primary care medical records: cross-sectional analyses from The Health Improvement Network (THIN) database
J. Taggar (2012)
10.1016/j.jhep.2008.05.023
Incidence and prevalence of cirrhosis in the United Kingdom, 1992-2001: a general population-based study.
K. Fleming (2008)
10.1136/gut.2004.058636
Trends in mortality after hospital admission for liver cirrhosis in an English population from 1968 to 1999
S. Roberts (2005)
10.2307/2530374
The analysis of failure times in the presence of competing risks.
R. Prentice (1978)
Long - term survival and causespecifi c mortality in patients with cirrhosis of the liver : a nationwide cohort study in Denmark
HT Sorensen (2003)
10.1053/JHEP.2003.50093
Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis
R. F. Velázquez (2003)
10.1002/hep.22341
Comorbidity and survival of Danish cirrhosis patients: A nationwide population‐based cohort study
P. Jepsen (2008)
Death certification and the epidemiologist
T Devis (1999)
10.1155/2013/291546
Obesity as a Major Risk Factor for Cancer
G. de Pergola (2013)
10.1038/ajg.2013.405
Diagnosis of Liver Cirrhosis in England, a Cohort Study, 1998–2009: A Comparison With Cancer
S. Ratib (2014)
10.1097/00001648-199201000-00002
Inaccuracies of death certificate information.
Flanders Wd (1992)
10.1097/00042737-199812000-00017
Risk of liver and other types of cancer in patients with cirrhosis: a nationwide cohort study in Denmark
H. Sørensen (1998)
10.1016/j.cgh.2012.09.007
Annual incidence of hepatocellular carcinoma among patients with alcoholic cirrhosis and identification of risk groups.
A. Mancebo (2013)
10.1002/HEP.510280404
Risk of liver and other types of cancer in patients with cirrhosis: A nationwide cohort study in Denmark
H. Sørensen (1998)
10.14236/JHI.V19I3.811
The history of the Read Codes: the inaugural James Read Memorial Lecture 2011.
T. Benson (2011)
10.1007/BF01320309
Survival and prognostic indicators in compensated and decompensated cirrhosis
G. D'Amico (2005)
10.1093/ije/dyr213
Competing risks in epidemiology: possibilities and pitfalls.
P. Andersen (2012)
Th e history of the Read codes : the inaugural James Read Memorial Lecture
T Benson (2011)
Linkage of the General Practice Research Database ( GPRD ) with other data sources
AM Gallagher (1997)
10.1016/j.jhep.2013.09.027
1 and 5 year survival estimates for people with cirrhosis of the liver in England, 1998-2009: a large population study.
S. Ratib (2014)
Inaccuracies of death certifi cate information
WD Flanders (2010)
10.1002/HEP.1840180109
A multivariate analysis of risk factors for hepatocellular carcinogenesis: A prospective observation of 795 patients with viral and alcoholic cirrhosis
K. Ikeda (1993)
10.1186/1472-6963-13-161
The communication of a secondary care diagnosis of autoimmune hepatitis to primary care practitioners: a population-based study
F. Varyani (2013)



This paper is referenced by
10.20514/2226-6704-2020-10-1-57-60
Выбор и классификация лекарственных препаратов при коморбидных заболеваниях
Ф. И. Белялов (2020)
10.2478/jtim-2019-0006
Management of Patients with Liver Cirrhosis and Invasive Bladder Cancer: A Case-series
Ioannis Zachos (2019)
10.1016/j.drugalcdep.2018.06.012
Ultrasound findings of liver damage in a series of patients consecutively admitted for treatment of alcohol use disorder.
Daniel Fuster (2018)
10.1111/apt.14341
Statins reduce the risk of liver decompensation and death in chronic viral hepatitis: a propensity score weighted landmark analysis
J. C. Wong (2017)
10.3390/ijerph17082825
Comorbidities and Outcome of Alcoholic and Non-Alcoholic Liver Cirrhosis in Taiwan: A Population-Based Study
Tzu-Wei Yang (2020)
10.1136/bmjopen-2015-009337
Modelling estimates of the burden of respiratory syncytial virus infection in children in the UK
S. Taylor (2016)
10.3109/00365521.2016.1157889
Incidence, survival and cause-specific mortality in alcoholic liver disease: a population-based cohort study
Perttu Sahlman (2016)
Cochrane Database of Systematic Reviews Secondary prevention of bleeding in people with previous oesophageal variceal bleeding due to decompensated liver cirrhosis: a network meta-analysis (Protocol)
Kurinchi Selvan Gurusamy (2018)
10.1016/S2468-1253(18)30379-0
Place of death and factors associated with hospital death in patients who have died from liver disease in England: a national population-based study.
Jen-Kuei Peng (2019)
10.1016/j.jhep.2018.09.014
Burden of liver diseases in the world.
Sumeet K. Asrani (2019)
10.3389/fphar.2018.00860
Acarbose Use and Liver Injury in Diabetic Patients With Severe Renal Insufficiency and Hepatic Diseases: A Propensity Score-Matched Cohort Study
C. Chao (2018)
10.1002/14651858.CD013125.PUB2
Antibiotic prophylaxis to prevent spontaneous bacterial peritonitis in people with liver cirrhosis: a network meta-analysis.
O. Komolafe (2020)
10.1002/14651858.CD013103.PUB2
Treatment for hepatorenal syndrome in people with decompensated liver cirrhosis: a network meta-analysis.
L. Best (2019)
10.1002/14651858.CD013120.PUB2
Antibiotic treatment for spontaneous bacterial peritonitis in people with decompensated liver cirrhosis: a network meta-analysis.
Laura Iogna Prat (2019)
10.1002/14651858.CD013122
Secondary prevention of bleeding in people with previous oesophageal variceal bleeding due to decompensated liver cirrhosis: a network meta‐analysis
K. Gurusamy (2018)
10.1016/j.rgmx.2020.01.002
Influencia los factores socioeconómicos y culturales en la etiología de la cirrosis hepática
Federico Roesch-Dietlen (2020)
10.4254/wjh.v9.i5.263
Malnutrition negatively impacts the quality of life of patients with cirrhosis: An observational study
G. Rojas-Loureiro (2017)
10.1053/j.gastro.2015.09.040
Transient and 2-Dimensional Shear-Wave Elastography Provide Comparable Assessment of Alcoholic Liver Fibrosis and Cirrhosis.
M. Thiele (2016)
10.1016/j.cgh.2019.07.060
Contemporary Epidemiology of Chronic Liver Disease and Cirrhosis.
A. Moon (2019)
10.1111/apt.13587
Editorial: in vino veritas – transient elastography for staging liver fibrosis in alcoholic liver disease – authors' reply
C. Pavlov (2016)
10.1096/fj.201800736R
Chronic ethanol‐mediated hepatocyte apoptosis links to decreased TET1 and 5‐hydroxymethylcytosine formation
Chengcheng Ji (2019)
10.1016/j.jid.2017.10.024
Risk of Incident Liver Disease in Patients with Psoriasis, Psoriatic Arthritis, and Rheumatoid Arthritis: A Population-Based Study.
A. Ogdie (2018)
10.1053/j.gastro.2018.01.005
Accuracy of the Enhanced Liver Fibrosis Test vs FibroTest, Elastography, and Indirect Markers in Detection of Advanced Fibrosis in Patients With Alcoholic Liver Disease.
M. Thiele (2018)
10.1111/apt.14627
Stabilisation of acute‐on‐chronic liver failure patients before liver transplantation predicts post‐transplant survival
P. Huebener (2018)
Error Assessment In The Application Of Foreign Life Tables In Ghana And Competing Risk Analysis
A. E. Aidoo (2017)
10.1002/14651858.CD013155
Treatment for bleeding oesophageal varices in people with decompensated liver cirrhosis: a network meta‐analysis
Danielle V. Roberts (2018)
10.1111/apt.13561
Editorial: in vino veritas – transient elastography for staging liver fibrosis in alcoholic liver disease
M. Thiele (2016)
10.1161/JAHA.116.004601
Incidence of First Stroke in Pregnant and Nonpregnant Women of Childbearing Age: A Population‐Based Cohort Study From England
L. Ban (2017)
10.1007/978-3-319-98890-0
The Human Gut-Liver-Axis in Health and Disease
Aleksander Krag (2019)
10.1253/circj.CJ-16-0849
Long-Term Outcome of Cardiac Surgery in 1,040 Liver Cirrhosis Patient - Nationwide Population-Based Cohort Study.
An-Hsun Chou (2017)
10.1002/pds.4747
The accuracy of date of death recording in the Clinical Practice Research Datalink GOLD database in England compared with the Office for National Statistics death registrations
A. Gallagher (2019)
10.1002/14651858.CD013123.PUB2
Treatment for ascites in adults with decompensated liver cirrhosis: a network meta-analysis.
A. Benmassaoud (2020)
See more
Semantic Scholar Logo Some data provided by SemanticScholar